ANESHAH WASHINGTON: Open Payments
NPI 1922880681 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,885 in 149 payments from 37 companies in 2025. Trend: 2023 $737 · 2024 $3,411 · 2025 $3,885
Food & beverage: $3,551Education: $333
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 9 | $429 |
| Janssen Biotech, Inc. | 17 | $405 |
| Daiichi Sankyo Inc. | 10 | $348 |
| AstraZeneca Pharmaceuticals LP | 6 | $245 |
| Merck Sharp & Dohme LLC | 11 | $212 |
| Novartis Pharmaceuticals Corporation | 14 | $187 |
| GlaxoSmithKline, LLC. | 5 | $167 |
| Aveo Pharmaceuticals, Inc. | 4 | $142 |
| Regeneron Healthcare Solutions, Inc. | 3 | $142 |
| Iovance Biotherapeutics, Inc. | 5 | $124 |
Products named: KEYTRUDA, MONJUVI, RYBREVANT, DATROWAY, FOTIVDA, LIBTAYO, ENHERTU, Amtagvi.
Industry payments across AR — which companies pay providers there.
